Dr. Markman Discusses the Olaparib Phase II Trial

Maurie Markman, MD
Published Online: Wednesday, May 18, 2011
Maurie Markman, MD the National Director for Medical Oncology for the Cancer Treatment Centers of America Discusses the Olaparib Phase II Trial
Online CME Activities
Free CME from PER
Immunotherapeutic Approaches to the Treatment of Squamous Non-Small Cell Lung Cancer
Clinical Vignettes in Multiple Myeloma
Clinical Vignette Series: Mitigating and Managing Adverse Events in Hematology
Angiogenesis Inhibitors for Gastrointestinal Cancers: Update From the 2015 Gastrointestinal Cancers Symposium
More Reading
$auto_registration$